Skip to content
Screener

MeiraGTx Holdings plc MGTX Other Income (Expense)

Other Income (Expense) at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$234.3M-46.7%
Opus Genetics logo
Opus GeneticsIRD
$844K+179%
Regenxbio logo
RegenxbioRGNX
-$6.55M+13.7%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$7.12M+10.0%
Prime Medicine logo
Prime MedicinePRME
$1.18M+49.6%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$4.86M-14.0%

Other financials

Income statement

See full
Revenue$293.0K-84.8%
Operating income-$40.8M+1.9%
Net income-$46.3M-15.8%
EPS (diluted)-$0.57-11.8%

Balance sheet

See full
Cash & equivalents$71.5M+7.5%
Total debt$62.7M-22.5%
Total equity-$58.1M-276%
Total assets$244.7M+9.2%

Cash flow

See full
Operating cash flow$17.8M+148%
CapEx$2.0M+17.4%
Free cash flow$15.8M+141%

Valuation

See full
Market cap$1.18B+85.4%
Enterprise value$1.18B+71.1%
P/S14.9×-2.0×

Profitability

See full
Operating margin-597.9%-207pp
Net margin-615.3%
FCF margin-441.5%-126pp

Returns & leverage

See full
Return on equity-379.5%
Debt / equity27.2×+26.1×
Current ratio0.5×-1.0×

Where this comes from

Reported directly by MeiraGTx Holdings plc in its filing.

Tagged under the XBRL concept us-gaap:ForeignCurrencyTransactionGainLossBeforeTax.

The source filing: MeiraGTx Holdings plc’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 8:30 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-060739
Line itemFor the Three-Month Periods Ended March 31, 2026For the Three-Month Periods Ended March 31, 2025
Total operating expenses41,11043,522
Loss from operations(40,817)(41,596)
Other non-operating income (expense):
Foreign currency (loss) gain(2,837)3,687
Interest income189971
Interest expense(2,848)(3,043)
Net loss(46,313)(39,981)
Other comprehensive gain (loss):

Item 1. Financial Statements (Unaudited)

FAQ

What is MeiraGTx Holdings plc's other income (expense)?
MeiraGTx Holdings plc (MGTX) reported other income (expense) of -$2.84M in Q1 2026.
How has MeiraGTx Holdings plc's other income (expense) changed year-over-year?
MeiraGTx Holdings plc's other income (expense) decreased by 176.9% year-over-year, from $3.69M to -$2.84M.
What is the long-term trend for MeiraGTx Holdings plc's other income (expense)?
Over 2 years (2021 to 2024), MeiraGTx Holdings plc's other income (expense) has grown at a -32.3% compound annual growth rate (CAGR), from -$6.29M to -$2.89M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Ask your AI about MeiraGTx Holdings plc's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude